Evaluation of the role of rhIL-11 on hematological recovery in lymphoma patients after autologous hematopoietic stem cell transplantation

Chinese Journal of Oncology

Volumn 34, Issue 6, 2012, Pages 469-472

  Yang, Jian Liang ^a   Shi, Yuan Kai ^a   He, Xiao Hui ^a   Dong, Mei ^a   Zhou, Sheng Yu ^a   Liu, Peng ^a   Zhang, Chang Gong ^a   Han, Xiao Hong ^a   Yang, Sheng ^a   Gui, Lin ^a   Qin, Yan ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Autologous hematopoietic stem cell transplantation; Lymphoma; Platelet; Recombinant human interleukin 11

Indexed keywords

RECOMBINANT INTERLEUKIN 11;

ABSENCE OF SIDE EFFECTS; ADVERSE OUTCOME; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER PATIENT; CONTROLLED STUDY; CONVALESCENCE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-11; LYMPHOMA; MALE; PLATELET COUNT; PLATELET TRANSFUSION; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 84864266943     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2012.06.015     Document Type: Article

References (0)